Streetbeat News

BHVN

Biohaven Ltd.

https://www.biohaven.com/

Industry

Biotechnology

Biohaven Ltd. is a clinical-stage biopharmaceutical company. The Company focuses on development of therapies for neurological and immunoscience diseases that can change current treatment paradigms.

Open

28.76

Mkt cap

Volume

654K

High

29.65

P/E Ratio

-3.14

52-wk high

60.46

Low

28.52

Div yield

N/A

52-wk low

26.80

Levi & Korsinsky has initiated an investigation into Biohaven Ltd., which may have implications for the company's stock and investor confidence.

Portfolio Pulse from

March 07, 2025 | 8:00 pm

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of Biohaven Ltd. investors, encouraging them to inquire about a securities investigation.

Portfolio Pulse from

March 07, 2025 | 3:15 pm

Levi & Korsinsky has initiated an investigation into Biohaven Ltd. (BHVN) concerning potential securities fraud allegations.

Portfolio Pulse from

March 06, 2025 | 3:45 pm

Bronstein, Gewirtz & Grossman, LLC has initiated an investigation into potential claims against Biohaven Ltd. (NYSE:BHVN) and is encouraging investors to reach out.

Portfolio Pulse from

March 06, 2025 | 3:15 pm

Levi & Korsinsky has initiated an investigation into Biohaven Ltd. for potentially misleading investors. This could have implications for the company's stock price and investor trust.

Portfolio Pulse from

March 05, 2025 | 3:45 pm

Bronstein, Gewirtz & Grossman, LLC has initiated an investigation into Biohaven Ltd. (BHVN) regarding potential claims. Stockholders are encouraged to contact the firm.

Portfolio Pulse from

March 05, 2025 | 3:15 pm

Levi & Korsinsky has initiated an investigation into potential securities fraud by Biohaven Ltd., which could have implications for investors.

Portfolio Pulse from

March 05, 2025 | 1:30 am

Pomerantz LLP is investigating claims on behalf of investors of Biohaven Ltd (NYSE: BHVN). Investors are encouraged to contact the law firm for more information.

Portfolio Pulse from

March 05, 2025 | 1:00 am

Levi & Korsinsky has initiated an investigation into Biohaven Ltd. for potential securities law violations. Investors are encouraged to contact the firm for more information.

Portfolio Pulse from

March 04, 2025 | 10:15 pm

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of Biohaven Ltd. (NYSE:BHVN) stockholders.

Portfolio Pulse from

March 04, 2025 | 5:15 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.